Genomic variants associated with primary biliary cirrhosis

Carlo Selmi, Natalia J Torok, Andrea Affronti, M. Eric Gershwin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autoreactive T cells acting against the lipoylated 2-oxoacid dehydrogenase complexes. The causes of the disease remain unknown, but environmental factors and genetic susceptibility both contribute to its onset. Over the past two decades several association studies have addressed the role of genetic polymorphisms in PBC pathogenesis and have reported multiple associations. However, only a few studies had sufficient statistical power, and in most cases results were not independently validated. A genome-wide association study has recently been reported, but this too awaits independent confirmation. The aim of this present work is to critically review the numerous studies dedicated to revealing genetic associations in PBC, and to predict the potential for future studies based on these data.

Original languageEnglish (US)
Article number5
JournalGenome Medicine
Volume2
Issue number1
DOIs
StatePublished - Jan 26 2010

Fingerprint

Biliary Liver Cirrhosis
Keto Acids
Genome-Wide Association Study
Genetic Polymorphisms
Genetic Predisposition to Disease
Bile Ducts
Liver Cirrhosis
Autoantibodies
Autoimmune Diseases
Oxidoreductases
T-Lymphocytes
Wounds and Injuries

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Biology
  • Molecular Medicine

Cite this

Genomic variants associated with primary biliary cirrhosis. / Selmi, Carlo; Torok, Natalia J; Affronti, Andrea; Gershwin, M. Eric.

In: Genome Medicine, Vol. 2, No. 1, 5, 26.01.2010.

Research output: Contribution to journalArticle

@article{26aab7e88b0b407e973f7284a36220cd,
title = "Genomic variants associated with primary biliary cirrhosis",
abstract = "Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autoreactive T cells acting against the lipoylated 2-oxoacid dehydrogenase complexes. The causes of the disease remain unknown, but environmental factors and genetic susceptibility both contribute to its onset. Over the past two decades several association studies have addressed the role of genetic polymorphisms in PBC pathogenesis and have reported multiple associations. However, only a few studies had sufficient statistical power, and in most cases results were not independently validated. A genome-wide association study has recently been reported, but this too awaits independent confirmation. The aim of this present work is to critically review the numerous studies dedicated to revealing genetic associations in PBC, and to predict the potential for future studies based on these data.",
author = "Carlo Selmi and Torok, {Natalia J} and Andrea Affronti and Gershwin, {M. Eric}",
year = "2010",
month = "1",
day = "26",
doi = "10.1186/gm126",
language = "English (US)",
volume = "2",
journal = "Genome Medicine",
issn = "1756-994X",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Genomic variants associated with primary biliary cirrhosis

AU - Selmi, Carlo

AU - Torok, Natalia J

AU - Affronti, Andrea

AU - Gershwin, M. Eric

PY - 2010/1/26

Y1 - 2010/1/26

N2 - Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autoreactive T cells acting against the lipoylated 2-oxoacid dehydrogenase complexes. The causes of the disease remain unknown, but environmental factors and genetic susceptibility both contribute to its onset. Over the past two decades several association studies have addressed the role of genetic polymorphisms in PBC pathogenesis and have reported multiple associations. However, only a few studies had sufficient statistical power, and in most cases results were not independently validated. A genome-wide association study has recently been reported, but this too awaits independent confirmation. The aim of this present work is to critically review the numerous studies dedicated to revealing genetic associations in PBC, and to predict the potential for future studies based on these data.

AB - Primary biliary cirrhosis (PBC) is an autoimmune hepatobiliary disease characterized by immune-mediated injury of small and medium-sized bile ducts, eventually leading to liver cirrhosis. Several studies have addressed PBC immunopathology, and the data support an immune activation leading to autoantibodies and autoreactive T cells acting against the lipoylated 2-oxoacid dehydrogenase complexes. The causes of the disease remain unknown, but environmental factors and genetic susceptibility both contribute to its onset. Over the past two decades several association studies have addressed the role of genetic polymorphisms in PBC pathogenesis and have reported multiple associations. However, only a few studies had sufficient statistical power, and in most cases results were not independently validated. A genome-wide association study has recently been reported, but this too awaits independent confirmation. The aim of this present work is to critically review the numerous studies dedicated to revealing genetic associations in PBC, and to predict the potential for future studies based on these data.

UR - http://www.scopus.com/inward/record.url?scp=78751688616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751688616&partnerID=8YFLogxK

U2 - 10.1186/gm126

DO - 10.1186/gm126

M3 - Article

C2 - 20193050

AN - SCOPUS:78751688616

VL - 2

JO - Genome Medicine

JF - Genome Medicine

SN - 1756-994X

IS - 1

M1 - 5

ER -